-

Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2025 Results on July 17

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release second quarter 2025 financial results on July 17, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

  • 888-947-9963 - Access Code - 3972058 (Domestic)
  • 312-470-0178 - Access Code - 3972058 (International)
  • 866-511-1890 - No Access Code (Domestic Replay)
  • 203-369-1945 - No Access Code (International Replay)

The replay will be available from 11:30 a.m. EDT on July 17, 2025, until the end of the day on August 15, 2025. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.

About Elevance Health

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve over 110 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

Contacts

Investor Relations:
Nathan Rich
Investor.Relations@elevancehealth.com

Media Relations:
Leslie Porras
Leslie.Porras@elevancehealth.com

Elevance Health, Inc.

NYSE:ELV

Release Versions

Contacts

Investor Relations:
Nathan Rich
Investor.Relations@elevancehealth.com

Media Relations:
Leslie Porras
Leslie.Porras@elevancehealth.com

More News From Elevance Health, Inc.

Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence

INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company’s board, effective August 1. He will also serve on the board’s Audit and Finance Committees, further enhancing the board’s industry expertise and financial oversight capabilities. His addition is part of the board’s ongoing commitment and structured approach to refresh its membership in support of the c...

Study Finds Digital Asthma Program Significantly Improves Symptom Control in Adults

INDIANAPOLIS--(BUSINESS WIRE)--Study by Elevance Health, UCI, in collaboration with Apple, highlights potential of digital health tools to reduce asthma burden in U.S. populations....

Elevance Health Reports Second Quarter 2025 Results

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results. "In the second quarter, Elevance Health made meaningful progress in delivering an experience that is simple and personal to those we serve, while advancing our efforts to enhance efficiency across the healthcare system. We are updating our outlook to reflect elevated medical cost trends in ACA and slower rate alignment in Medicaid. While the external environment continues to evolve, we are foc...
Back to Newsroom